Organogenesis Holdings, Inc.

ORGO

On October 12, 2021, Value Investors Club issued a report alleging issues at Organogenesis Holdings, Inc., indicating that the wound care medical company has been improperly billing the federal government for $250 million annually. The Company also set the price for its new wound covering, Affinity, “exorbitantly high”, which Medicare reimbursed, while making the product lucrative for doctors to use through large rebates.  

On this news, shares of Organogenesis Holdings fell over 18% in intraday trading on October 12, 2021.

Lead Plaintiff deadline
class period
to
Case Documents
No documents available. Contact us if you need a case document.